⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAZZ News
Jazz Pharmaceuticals, Inc.
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline
globenewswire.com
JAZZ
LLY
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
globenewswire.com
NVS
JNJ
VRTX
BMY
JAZZ
Circana Announces its Annual Global Toy Industry Performance Award Winners
globenewswire.com
MAT
DIS
HAS
JAZZ
KIDS
Exosome Therapy Market Projected to Reach US$ 309.60 Billion by 2035, Supported by Clinical Translation and Manufacturing Scale-Up Says Astute Analytica
globenewswire.com
TAK
JAZZ
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
Jazz Icon Wynton Marsalis Headlines Festival Napa Valley’s 20 th Anniversary Arts for All Gala, July 12, 2026
businesswire.com
JAZZ
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight
globenewswire.com
LULU
LIVN
AXSM
TAK
JAZZ
VNDA
LLY
AVDL
New Milestone Unlocked: Frontiers Online Becomes a Founding Member of the Haidian Technology Self-Media Committee and a Council Member of the Network Influencers Association, Officially Joining the Core Communication Ecosystem
prnewswire.com
JAZZ
SI
Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer
globenewswire.com
JAZZ